Cargando…

Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review

Structure-based virtual screening (SBVS) has been widely applied in early-stage drug discovery. From a problem-centric perspective, we reviewed the recent advances and applications in SBVS with a special focus on docking-based virtual screening. We emphasized the researchers’ practical efforts in re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Tiejun, Li, Qingliang, Zhou, Zhigang, Wang, Yanli, Bryant, Stephen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282008/ https://www.ncbi.nlm.nih.gov/pubmed/22281989 http://dx.doi.org/10.1208/s12248-012-9322-0

Ejemplares similares

Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining
por: Cheng, Tiejun, et al.
Publicado: (2011)

Binary Classification of Aqueous Solubility Using Support Vector Machines with Reduction and Recombination Feature Selection
por: Cheng, Tiejun, et al.
Publicado: (2011)

Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge
por: Takeda, Takako, et al.
Publicado: (2017)

PubChem BioAssay: A Decade’s Development toward Open High-Throughput Screening Data Sharing
por: Wang, Yanli, et al.
Publicado: (2017)

A novel method for mining highly imbalanced high-throughput screening data in PubChem
por: Li, Qingliang, et al.
Publicado: (2009)

Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
por: Lionta, Evanthia, et al.
Publicado: (2014)

Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules
por: Cheng, Tiejun, et al.
Publicado: (2010)

ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening
por: Issa, Naiem T., et al.
Publicado: (2022)

Pathway Analysis for Drug Repositioning Based on Public Database Mining
por: Pan, Yongmei, et al.
Publicado: (2014)

Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery
por: Choi, Tae-Woo, et al.
Publicado: (2018)

MAGI-MS: multiple seed-centric module discovery
por: Chow, Julie C, et al.
Publicado: (2022)

In silico virtual screening approaches for anti-viral drug discovery
por: Murgueitio, Manuela S., et al.
Publicado: (2012)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Hierarchical virtual screening approaches in small molecule drug discovery
por: Kumar, Ashutosh, et al.
Publicado: (2015)

Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing
por: Xie, Li, et al.
Publicado: (2019)

Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
por: Ge, Huizhen, et al.
Publicado: (2022)

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
por: Vázquez, Javier, et al.
Publicado: (2020)

Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays
por: Zhou, Wenfang, et al.
Publicado: (2018)

Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
por: Carpenter, Kristy A., et al.
Publicado: (2018)

Lead Discovery Using Virtual Screening
por: Bikker, Jack Andrew, et al.
Publicado: (2009)

Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays
por: Huang, Shenzhen, et al.
Publicado: (2019)

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
por: Atatreh, Noor, et al.
Publicado: (2019)

An open-source drug discovery platform enables ultra-large virtual screens
por: Gorgulla, Christoph, et al.
Publicado: (2020)

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
por: Loi, Elena M., et al.
Publicado: (2022)

A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years
por: Zhu, Hui, et al.
Publicado: (2022)

Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria
por: Nazarshodeh, Elmira, et al.
Publicado: (2021)

An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
por: Ruiz-Torres, Verónica, et al.
Publicado: (2017)

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
por: Liu, Shan-Kui, et al.
Publicado: (2021)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
por: Kumar, Rajnish, et al.
Publicado: (2017)

Virtual Screening in Lead Discovery: A Viewpoint†
por: Oprea, Tudor Ionel
Publicado: (2002)

Virtual screening for the discovery of bioactive natural products
por: Rollinger, Judith M., et al.
Publicado: (2008)

Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery
por: Zauhar, Randy J., et al.
Publicado: (2013)

Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling
por: Gruener, Robert F., et al.
Publicado: (2021)

Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
por: Wang, Yuwei, et al.
Publicado: (2020)

Discovery of Chitin Deacetylase Inhibitors through Structure-Based Virtual Screening and Biological Assays
por: Liu, Yaodong, et al.
Publicado: (2022)

Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
por: Gomes, Bárbara Figueira, et al.
Publicado: (2023)

Discovery of Novel Human Epidermal Growth Factor Receptor-2 Inhibitors by Structure-based Virtual Screening
por: Shi, Zheng, et al.
Publicado: (2016)

Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents
por: Chuang, Chih-Hung, et al.
Publicado: (2015)

Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer
por: Aziz, Mubashir, et al.
Publicado: (2022)

Structure-Based Virtual Screening towards the Discovery of Novel ULK1 Inhibitors with Anti-HCC Activities
por: Gao, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p6gqgvr1oub88o8jeil0e6oqe1